Eric Belin, MD
Dermatology · Bella Vista, ARNPI 1134105042
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.5% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Johnson & Johnson at 26.6% of the total.
Across 285 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$862
- Novartis$818
- Lilly USA, LLC$457
- Sanofi$386
- UCB, Inc.$243
- plus $1K from 16 others
What the payments were for
- Food & beverage$5,10794%
- Education$3546%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 62 | $1,451 |
| AbbVie | 56 | $862 |
| Novartis | 42 | $818 |
| Lilly USA, LLC | 23 | $457 |
| Sanofi | 17 | $386 |
| UCB, Inc. | 13 | $243 |
| Pfizer | 14 | $225 |
| Regeneron Healthcare Solutions, Inc. | 7 | $143 |
| Galderma Laboratories, L.p. | 9 | $133 |
| Dermavant Sciences, Inc. | 8 | $118 |
| E.r. Squibb & Sons, L.L.C. | 5 | $104 |
| Dermira, Inc. | 4 | $68 |
| Sun Pharmaceutical Industries Inc. | 3 | $66 |
| Organon | 4 | $63 |
| Genentech USA, Inc. | 4 | $63 |
| VYNE Pharmaceuticals Inc. | 3 | $59 |
| LEO Pharma Inc. | 3 | $57 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $50 |
| Amgen | 2 | $37 |
| Dexcom, Inc. | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $17 |
| Bristol Myers Squibb | 1 | $12 |
How this compares
$5,461 in reported general payments places this provider in the 65th percentile of 75 dermatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $81,630 |
| Clobetasol Propionate | 96 | $3,295 |
| Metronidazole | 21 | $1,638 |
| Fluorouracil | 11 | $1,253 |
| Triamcinolone Acetonide | 63 | $1,113 |
| Ketoconazole | 58 | $897 |
| Doxycycline Hyclate | 32 | $587 |
| Gabapentin | 23 | $205 |
| ValacyclovirValacyclovir Hcl | 14 | $196 |
| Mupirocin | 19 | $162 |
| MethotrexateMethotrexate Sodium | 16 | $143 |
| Hydrocortisone | 13 | $105 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bella Vista
- Sandra JohnsonFort Smith$543K
- Scott JacksonFayetteville$533K
- Mildred CliftonBentonville$92K
- Lance HenryFayetteville$39K
- Jennifer JacksPine Bluff$21K
- Zachary NahmiasJonesboro$15K
- Phillip StitesFort Smith$15K
- Brian WayneLittle Rock$13K
- Andrea MabryLittle Rock$12K
- Thomas ManningLittle Rock$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.